Fundamental concepts in the pathobiology of heparin-induced thrombocytopenia

Journal of Thrombosis and Thrombolysis

Volumn 10, Issue SUPPL. 1, 2000, Pages

  Januzzi J L , Jr ^a   Jang, I K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Heparin; HIT; Pathophysiology; Thrombocytopenia

Indexed keywords

ABCIXIMAB; ARGATROBAN; BETA LACTAM ANTIBIOTIC; DANAPAROID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN RECEPTOR; HEPARIN; HEPARINOID; HIRULOG; HYDRAZINE; INTERLEUKIN 8; ISONIAZID; LOW MOLECULAR WEIGHT HEPARIN; PADGEM PROTEIN; PROCAINAMIDE; PROTEOHEPARAN SULFATE; QUININE DERIVATIVE; RECOMBINANT HIRUDIN; THROMBOCYTE FACTOR 4;

ANTIBODY PRODUCTION; BINDING AFFINITY; BLEEDING; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CROSS LINKING; DRUG INDUCED DISEASE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; ENDOTHELIUM INJURY; GENETIC POLYMORPHISM; HUMAN; HYPERPLASIA; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOSIS;

ANTICOAGULANTS; CHEMOTAXIS, LEUKOCYTE; CROSS REACTIONS; ENDOTHELIUM, VASCULAR; EPITOPES; HEPARIN; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; PLATELET ACTIVATION; PLATELET FACTOR 4; THROMBOCYTOPENIA; THROMBOPHILIA; THROMBOSIS;

EID: 0034514919     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Heparin-induced thrombocytopenia
2. Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro
3. Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenia purpura, systemic lupus erythematosus, and other clinical disorders
4. Acute, profound thrombocytopenia after C7E3 Fab (abciximab) therapy
5. Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion
6. Gold-induced thrombocytopenia
7. Prevalence and significance of hematological abnormalities in patients with systemic lupus erythematosis
8. Heparin-induced thrombocytopenia: Diagnosis and contemporary antithrombin management
9. A 14-year study of heparin-induced thrombocytopenia
10. Heparin-induced thrombocytopenia (HIT) due to heparin line flushes: A report of three cases
11. Thrombocytopenia associated with heparin-associated antiplatelet antibodies
12. Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses
13. Chemokines
14. Purification and binding properties of human platelet factor 4
15. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia
16. Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-alpha. Induction of a partially folded state and implications for heparin-induced thrombocytopenia
17. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin platelet factor 4
18. Complexes of heparin and platelet factor 4 specifically stimulate T-cells from patients with heparin-induced thrombocytopenia/thrombosis
19. Presence of autoantibodies to interleukin-8 or neutrophil activating peptide-2 in patients with heparin-associated thrombocytopenia
20. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells
21. 131) gene in patients with heparin-induced thrombocytopenia
22. Heparin-induced thrombocytopenia: New insights into the impact of the FcγRIIA-R-H131 polymorphism
23. Importance of the FcγRIIA-Arg/HIS-131 polymorphism in heparin-induced thrombocytopenia diagnosis
24. Platelet surface glycoproteins: Studies on resting and activated platelets and platelet membrane microparticles in normal subjects and observations in patient during adult respiratory distress syndrome and cardiac surgery
25. Agglutination of isolated platelet membranes
26. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia
27. Heparin-induced thrombocytopenia and thrombosis: Clinical and laboratory studies
28. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa dependent mechanism
29. Immune endothelial-cell injury in heparin-associated thrombocytopenia
30. Endothelial cell hyperplasia contributes to thrombosis in heparin-induced thrombocytopenia
31. Effect of SR121566A, a potent GP IIb/IIIa antagonist on the HIT serum/heparin-induced platelet mediated activation of human endothelial cells
32. Selectins in the HIT syndrome: Pathophysiologic role and therapeutic modulation
33. The selectins: Vascular adhesion molecules